Hydrogen peroxide vapor (HPV) is a well-known bio-decontaminating agent that deactivates microorganisms more effectively and at a rate faster than conventional decontaminating agents such as formaldehyde. This residue-free bio-decontamination process comprises of the deposition of a layer of HPV micro-condensation over the required surface, eventually deactivating microorganisms.
HPV decontamination systems are cost effective and as a result are the go-to methods of decontamination in hospitals, laboratories, and clinical research institutes. Apart from these, global HPV decontamination systems market also find application in the aviation and aerospace industries. Cleaning an entire aircraft or spacecraft can be immensely time consuming and tedious – whether they are cleaned manually or with the help of robots, and HPV decontamination systems offer near-complete decontamination without any harmful byproducts and no need for supervision.
Recognizing the benefits presented by HPV decontamination systems, an increasing number of players have been operating in the global market. Some of the leading companies in this space are Sterilucent, Inc, SKAN AG, Steris Corporation, Bioquell, plc, Panasonic Biomedical Sales Europe BV, Mbraun Inc., TOMI Environmental Solutions, Inc., Getinge Group, Howorth Air Technology, Fedegari Autoclavi SpA, and Labotal Scientific Equipment (1997) Ltd.
Rising Incidence of Hospital-Acquired Infections Driving Demand for HPV Decontamination Systems
One of the most significant factors fueling the demand for HPV decontamination systems is the increasing incidence of hospital-acquired infections (HAIs). The Centers for Disease Control and Prevention (CDC) in the US finds that an estimated one in 25 hospital patients is infected by at least one HAI on any given day. A 2014 HAI Prevalence Survey found that around 722,000 HAIs were reported in acute care hospitals in the US in 2011, with an additional 75,000 patients dying due to HAIs during their hospital stay.
Regularly cleaning and decontaminating minimizes the risk of microbial infections in several surroundings. Hence, the growing demand for the prevention of viral and bacterial infections has greatly supported the global market for HPV decontamination systems. Driven by this factor, leading business intelligence firm Transparency Market Research estimates that the market is likely to expand at a 6.7% CAGR from 2016 to 2024, with the value poised to rise from US$122.7 mn to US$220 mn therein.
Growing Demand for Decontamination of Laboratory-scale Incubators
HPV decontamination systems find application in isolators, incubators, autoclave/cage washers, and facilities and rooms. Incubators are commonly used in laboratory environments for applications such as neuroscience, cell culturing, in-vitro fertilization, tissue engineering, stem cell research, cancer research, and embryonic stem cell research. They are also used for the cultivation of mammalian cells. The rising usage of laboratory-scale incubators often results in accidental spillage and may often require to be changes based on the requirements of the research. This, in turn, warrants the need for regular decontamination, thereby driving the demand for HPV decontamination systems. Accounting for a 30% share in the overall HPV decontamination systems market in 2015, the use of these systems in incubators generated a revenue amounting to US$39.8 mn.
Browse Full Global HPV Decontamination Systems Market Report with TOC :http://www.mrrse.com/hpv-decontamination-systems-market
The application of HPV decontamination systems in isolators is projected to expand at a rapid pace by 2024, registering a strong CAGR of 7.9% during the forecast period. Isolators are widely used in sterility testing and owing to its use of advanced barrier technologies to cut the risks of contamination, their usage rate is anticipated to pick up pace.